So it's been a long series, and I want to thank everyone for checking it out. And if you missed it, my 'home run' pick in healthcare, Ocera Therapeutics (NASDAQ:OCRX) jumped over 25% since the article was published, although it gave back some of those gains at closing yesterday. And Acadia Pharmaceuticals (NASDAQ:ACAD) has been lagging behind the sector as predicted, and the short thesis behind Questcor (QCOR) is getting pummeled as well. Finally, Novavax (NASDAQ:NVAX) has soared over 15% since calling the company a top buyout pick this year.
I saved my short pick(s) for last because these candidates have generally produced the best and fastest gains in my career. So...
|FREE||SA PRO MEMBERS|
|IDEA GENERATOR||X||Exclusive access to 10 PRO ideas every day|
|INVESTING IDEAS LIBRARY||X||Exclusive access to PRO library of more than 15,000 ideas|
|SECTOR EXPERT NETWORK||X||Exclusive access to all sector experts for direct consultation|
|PERFORMANCE TRACKING||X||Track performance of all PRO stock ideas|
|PROFESSIONAL TOOLS||X||Professional Idea Filters to zero-in based on industry, market cap and more|